Christopher D. Maggiore - 21 Oct 2021 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
Director, 10%+ Owner
Signature
/s/ Christopher D. Maggiore
Issuer symbol
ZIVO
Transactions as of
21 Oct 2021
Net transactions value
$0
Form type
4
Filing time
25 Oct 2021, 19:07:22 UTC
Previous filing
15 Oct 2021
Next filing
14 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Award $0 +42,000 $0.000000 42,000 21 Oct 2021 Common Stock 42,000 $5.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% upon acceptance of the grant, 25% on each of the next two 4-month anniversaries of the grant, and 25% on the day prior to the Company's 2022 Annual Meeting of Stockholders.